NasdaqGS - Delayed Quote USD

XBiotech Inc. (XBIT)

8.21 +0.14 (+1.73%)
At close: April 25 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. John Simard Founder, President, CEO & Chairman 5.56M -- 1962
Dr. Sushma Shivaswamy Ph.D. Chief Scientific Officer 449.99k -- 1978
Ms. Angela Hu Director of Finance, Principal Financial & Accounting Officer and Financial Controller 198.13k -- 1984

XBiotech Inc.

5217 Winnebago Lane
Austin, TX 78744
United States
512 386 2900 https://www.xbiotech.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
82

Description

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Corporate Governance

XBiotech Inc.’s ISS Governance QualityScore as of April 1, 2024 is 8. The pillar scores are Audit: 9; Board: 7; Shareholder Rights: 5; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 08, 2024 - May 13, 2024
XBiotech Inc. Earnings Call

Related Tickers

XLS.SW Xlife Sciences AG
34.30
0.00%
 
BION.SW BB Biotech AG
40.45
-0.25%
 
WVE Wave Life Sciences Ltd.
4.7400
-5.39%
 
HLVX HilleVax, Inc.
12.02
-4.45%
 
HOWL Werewolf Therapeutics, Inc.
6.21
-2.82%
 
CNTA Centessa Pharmaceuticals plc
8.93
-5.60%
 
TYRA Tyra Biosciences, Inc.
15.11
-5.56%
 
ANEB Anebulo Pharmaceuticals, Inc.
2.7944
+5.05%
 
BDTX Black Diamond Therapeutics, Inc.
5.11
+0.99%
 
MGTX MeiraGTx Holdings plc
4.7100
-3.09%